Recent studies have shown that eEF2 is overexpressed in several cancers, including gastrointestinal cancers and lung adenocarcinoma, where elevated levels correlate with increased tumor incidence and poorer patient prognosis [9, 10]. Here, EEF2 is linked to cancer.